Literature DB >> 22588757

Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).

Juanita Romero-Diaz1, David Isenberg, Rosalind Ramsey-Goldman.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22588757      PMCID： PMC3812450          DOI： 10.1002/acr.20572

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  54 in total

1.  From BILAG to BLIPS--disease activity assessment in lupus past, present and future.

Authors:  D A Isenberg; C Gordon
Journal:  Lupus       Date:  2000       Impact factor: 2.911

2.  Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus.

Authors:  S C Bae; H K Koh; D K Chang; M H Kim; J K Park; S Y Kim
Journal:  Lupus       Date:  2001       Impact factor: 2.911

3.  Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus.

Authors:  P Rahman; D D Gladman; M B Urowitz; D Hallett; L S Tam
Journal:  Lupus       Date:  2001       Impact factor: 2.911

4.  The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.

Authors:  D D Gladman; C H Goldsmith; M B Urowitz; P Bacon; P Fortin; E Ginzler; C Gordon; J G Hanly; D A Isenberg; M Petri; O Nived; M Snaith; G Sturfelt
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

5.  Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.

Authors:  M M Ward; A S Marx; N N Barry
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

6.  Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation.

Authors:  A J Swaak; H G van den Brink; R J Smeenk; K Manger; J R Kalden; S Tosi; A Marchesoni; Z Domljan; B Rozman; D Logar; G Pokorny; L Kovacs; A Kovacs; P G Vlachoyiannopoulos; H M Moutsopoulos; H Chwalinska-Sadowska; B Dratwianka; E Kiss; N Cikes; A Branimir; M Schneider; R Fischer; S Bombardieri; M Mosca; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  1999-10       Impact factor: 7.580

7.  Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Authors:  R J Cook; D D Gladman; D Pericak; M B Urowitz
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

8.  The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus.

Authors:  M Mosca; W Bencivelli; C Vitali; P Carrai; R Neri; S Bombardieri
Journal:  Lupus       Date:  2000       Impact factor: 2.911

9.  Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.

Authors:  Chee-Seng Yee; Vernon Farewell; David A Isenberg; Athiveeraramapandian Prabu; Katharina Sokoll; Lee-Suan Teh; Anisur Rahman; Ian N Bruce; Bridget Griffiths; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; Simon Bowman; Peter Maddison; Asad Zoma; Elizabeth Allen; Caroline Gordon
Journal:  Arthritis Rheum       Date:  2006-10

10.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666
View more
  55 in total

Review 1.  Top 10 things to know about lupus activity measures.

Authors:  Aikaterini Thanou; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

2.  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus.

Authors:  Begum Horuluoglu; Defne Bayik; Neslihan Kayraklioglu; Emilie Goguet; Mariana J Kaplan; Dennis M Klinman
Journal:  J Autoimmun       Date:  2019-01-22       Impact factor: 7.094

3.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

4.  Basophil count, a marker for disease activity in systemic lupus erythematosus.

Authors:  Peifen Liang; Ying Tang; Sha Fu; Jun Lv; Bo Liu; Min Feng; Jinggao Li; Deyuan Lai; Xia Wan; Anping Xu
Journal:  Clin Rheumatol       Date:  2014-11-19       Impact factor: 2.980

5.  Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.

Authors:  Alimohammad Fatemi; Ahmad Raeisi; Zahra Sayedbonakdar; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2017-12-18       Impact factor: 2.980

6.  Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients.

Authors:  Yichao Wang; Jiaogui Xie; Zhili Liu; Hongwei Fu; Qianyu Huo; Yajun Gu; Yunde Liu
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

7.  Is thrombocytosis always an indicator of autosplenectomy in patients with systemic lupus erythematosus?

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Ahmet Musmul; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2017-11-08       Impact factor: 2.631

8.  Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7.

Authors:  Valentina Salvi; Veronica Gianello; Sara Busatto; Paolo Bergese; Laura Andreoli; Ugo D'Oro; Alessandra Zingoni; Angela Tincani; Silvano Sozzani; Daniela Bosisio
Journal:  JCI Insight       Date:  2018-05-17

9.  Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Authors:  V Jucaud; M H Ravindranath; P I Terasaki; L E Morales-Buenrostro; F Hiepe; T Rose; R Biesen
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

10.  Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients.

Authors:  Marco Quaglia; Annalisa Chiocchetti; Tiziana Cena; Claudio Musetti; Sara Monti; Nausicaa Clemente; Umberto Dianzani; Corrado Magnani; Piero Stratta
Journal:  Clin Rheumatol       Date:  2014-05-13       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.